// Press Release
Join the Fight Against Mental Illness: View Life Through Gratitude Lenses
Join the Fight Against Mental Illness: View Life Through Gratitude Lenses San Diego, CA, January 12, 2021 — The lens through which we view our experiences in life can have a profound impact on how we react to the world around us. Following his father’s death by suicide, Daniel Hack had a decision to make. He … Continue reading Join the Fight Against Mental Illness: View Life Through Gratitude Lenses
Health Canada approves Lundbeck’s (Pr)VYEPTI® (eptinezumab)—the first and only intravenous preventive treatment for migraine
Health Canada approves Lundbeck’s (Pr)VYEPTI® (eptinezumab)—the first and only intravenous preventive treatment for migraine MONTREAL, Jan. 12, 2021 /CNW Telbec/ – Lundbeck is pleased to announce that VYEPTI® (eptinezumab) has been approved by Health Canada for the preventive treatment of migraine in adults who have at least 4 migraine days per month. Michal Juul Sørensen, Vice President … Continue reading Health Canada approves Lundbeck’s (Pr)VYEPTI® (eptinezumab)—the first and only intravenous preventive treatment for migraine
Caught in the Grip of COVID Stress? Nine Quick and Easy Ways to Stop Stress in the Moment
Caught in the Grip of COVID Stress? Nine Quick and Easy Ways to Stop Stress in the Moment Even when stress levels skyrocket, you can reclaim a sense of calm and control. Mark Goulston, MD, and Diana Hendel, PharmD, share simple ways frontline healthcare employees can lower their stress anytime, anyplace. Nashville, TN (January 2021)—After a … Continue reading Caught in the Grip of COVID Stress? Nine Quick and Easy Ways to Stop Stress in the Moment
Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab MONTREAL and PLANEGG/MUNICH, Germany, Jan. 12, 2021 /CNW/ – Incyte (NASDAQ: INCY) and MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; NASDAQ: MOR) today announced that Health Canada has accepted the New Drug Submission (NDS) for tafasitamab, an anti-CD19 … Continue reading Incyte and MorphoSys Announce Acceptance by Health Canada of the New Drug Submission for Tafasitamab
Multi-Cultural Channel for Youth on YouTube collaborates with world’s leading ebook app to offer youth both an audience and the opportunity to learn modern literacy skills for a changing world.
Multi-Cultural Channel for Youth on YouTube collaborates with world’s leading ebook app to offer youth both an audience and the opportunity to learn modern literacy skills for a changing world. NEW YORK (PRWEB) JANUARY 12, 2021 Questions around shrinking attention spans have been a popular area of research, but is it about quantity or is it … Continue reading Multi-Cultural Channel for Youth on YouTube collaborates with world’s leading ebook app to offer youth both an audience and the opportunity to learn modern literacy skills for a changing world.
The Fertility Partners Welcomes Another IVF Centre to its Growing Network, The Toronto Institute For Reproductive Medicine, and Acquires Sperm Bank ReproMed
The Fertility Partners Welcomes Another IVF Centre to its Growing Network, The Toronto Institute For Reproductive Medicine, and Acquires Sperm Bank ReproMed The rapidly growing partnership of leading fertility clinics expands its Ontario presence TORONTO, Jan. 13, 2021 /CNW/ – The Fertility Partners (“TFP”), Canada’s leading platform of fertility practices, announced today the acquisition of The Toronto Institute For Reproductive … Continue reading The Fertility Partners Welcomes Another IVF Centre to its Growing Network, The Toronto Institute For Reproductive Medicine, and Acquires Sperm Bank ReproMed
Health Canada Approves IMBRUVICA®* (ibrutinib) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
Health Canada Approves IMBRUVICA®* (ibrutinib) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL) Patients aged 70 or younger with previously untreated CLL lived longer without disease progression compared to patients treated with FCR, a chemoimmunotherapy regimen TORONTO, Jan. 13, 2021 /CNW/ – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today … Continue reading Health Canada Approves IMBRUVICA®* (ibrutinib) Plus Rituximab for the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)
CARDIO SPORTAnnounces Livestream Event Series Kicking off on Friday, January 29thFeaturing Ryan Key of Yellowcard & Derek Sanders of Mayday Parade
CARDIO SPORTAnnounces Livestream Event SeriesKicking off on Friday, January 29thFeaturing Ryan Key of Yellowcard & Derek Sanders of Mayday ParadeRegister Now January 13, 2021 – The Workout of Sports™ brought to you by Cardio Sport®, is the most fun, dynamic and innovative fitness training program that both novices and gurus will ever experience. The brand is excited … Continue reading CARDIO SPORTAnnounces Livestream Event Series Kicking off on Friday, January 29thFeaturing Ryan Key of Yellowcard & Derek Sanders of Mayday Parade
Rheumatoid arthritis patients at heightened risk for life-threatening blood clot
Rheumatoid arthritis patients at heightened risk for life-threatening blood clot VANCOUVER, BC, Jan. 13, 2021 /CNW/ – A new Arthritis Research Canada study reveals rheumatoid arthritis patients have an increased risk of cardiovascular disease after diagnosis compared to the general population. Researchers specifically looked at the risk of venous thromboembolism (VTE) – a blood clot that starts in … Continue reading Rheumatoid arthritis patients at heightened risk for life-threatening blood clot
Salvation: It Should Not Be Complicated or Confusing
Salvation: It Should Not Be Complicated or Confusing Dallas, TX, January 11, 2021— “What do I have to do to be saved?” is the Christian faith’s most important question and one that Lucas Kitchen started asking as a young boy. It should have been an easy question to answer, though no one in the piney … Continue reading Salvation: It Should Not Be Complicated or Confusing
